Stay updated on Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Sign up to get notified when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.

Latest updates to the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedHong Kong SAR is added as a study location under Locations (revision v3.3.3).SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the page (shown in the site header/footer). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision label, v3.3.1, was added. The previous revision label, v3.2.0, was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedA site-wide funding-status notice banner was removed, so the page now presents the study details without the previous funding-delay warning.SummaryDifference0.4%

- Check67 days agoChange DetectedThe updates show only minor UI and textual adjustments across sections such as Study Overview and Eligibility Criteria, with no changes to the study design, status, endpoints, or participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

Stay in the know with updates to Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Checkpoint vs Target Therapy for HBsAg+ HCC Clinical Trial page.